KLK3 and cancer: Although the incidence of PCa has more than tripled between 1990 and 2015 (4), also due to an increase in the diffusion of prostate-specific antigen (PSA) screening that aided in early cancer detection and diagnosis (5), mortality rates have been decreasing in most Western countries thanks to improved diagnosis and treatment (6).